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 ABSTRACT 
 Objectives: To compare different respiratory patterns on upper limb exercise  
capacity in patients with COPD. 
 
 Methods: Twenty two COPD patients were recruited in the study from various 
hospital and old age homes across Mangalore. Upper limb exercise capacity was 
measured in all four types of exercises two shoulder flexion-extension (one 
associated with inspiratory time during the concentric phase and the other 
associated with expiratory time) and two shoulder abduction-adduction (same 
timing as above). Borg's score and heart rate was noted pre and post UL 
exercise testing, Recovery both subjective and objective was noted post exercise 
testing Statistical analysis was done using Shapiro wilk test, independent t-test. 
Wilcoxon signed Ranked t-test, and Friedman test. 
  
Results: The patient with COPD were able to perform better for longer duration 
with inverted breathing pattern (expiration during concentric phase of UL 
movement involving exercise 2 and exercise 4) when compared with the results 
of exercise frequently applied in clinical practice (inspiration during concentric 
phase of UL movement involving exercise 1 and exercise 3). There was 
significant difference in duration for which exercise test was performed between 
exercise 1 and exercise 2 with p-value of 0.002, between exercise 3 and exercise 
4 with p-value <0.001. In addition among the studied exercises, exercise 4 
shows significant increase in Spo2 post exercises (p-value < 0,001) with 
prolonged recovery 2 (objective) period for the same exercise suggesting that 
the gain in Spo2 was maintained for longer time as compare to other exercise. 
Conclusion: The exercises performed with inverted respiratory time (exercise 2 
and exercise 4) were able to perform better than other exercise (exercise 1 and 
exercise 3) and can be used as important strategies during physical exercise 
programs in these patients.  
Keywords: COPD, Respiratory exercise pattern (breathing exercise), 
Physiotherapy, Upper limb exercise capacity. 
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INTRODUCTION 
 
Chronic obstructive pulmonary disease (COPD) is a common preventable 
and treatable disease which is characterized by persistent airflow limitation that 
is usually and associated with an enhanced chronic inflammatory response in 
the airways and the lung to noxious particles and gases. Exacerbations and co-
morbidities contribute to the overall severity in individual patients. 
(1)
  
The chronic airflow limitation characteristic of COPD is caused by a 
mixture of small airway disease (obstructive bronchiolitis) and parenchymal 
destruction (emphysema), the relative contributions of which vary from person 
to person. Chronic inflammation causes structural changes and narrowing of the 
small airways. Destruction of lung parenchyma, also by inflammatory process, 
leads to the loss of alveolar attachments to the small airways and decrease lung 
elastic recoil; in turn, these changes diminish the ability of the airway to remain 
open during expiration. 
(1)
 
 Globally, COPD has emerged as the major cause of morbidity and 
mortality expected to become the 3" most leading cause of death and leading 
cause of loss of "Disability Adjusted Life Years as per projection of the global 
burden of disease study. 
(1)
  
 COPD is a global health issue, with cigarette smoking being an 
important risk factor universally; other factors, such as exposure to indoor and 
outdoor air pollution. occupational hazards, infections, gender, genetic factors 
(deficiency of the serine protease al antitrypsin), ageing, asthma, and socio-
economic status. 
(3)
  
 Tobacco smoking is the main risk factor for COPD, although other 
inhaled noxious particles and gases may contribute. This causes an 
inflammatory response in the lung, which is exaggerated in some smokers, and 
leads to the characteristic pathological lesions of COPD. In addition to 
inflammation, an imbalance of proteinases and anti proteinases in the lungs, and 
oxidative stress are also important in the pathogenesis of  COPD. 
(4)
 
 According to the GOLD (Global Initiative for Chronic Obstructive Lung 
Disease) guidelines, a diagnosis of COPD can be established by a fixed ratio of 
post  bronchodilator  FEV1 and FVC below 0.7 measured by spirometer (3) The 
spirometric severity is graded according to the percentage o FEV1 predicted 
(GOLD stage I-IV). This functional definition, based on airflow limitation, has 
been used to characterize the disease until now, but, obviously, the degree of 
airflow limitation is only one aspect in the risk assessment of patients with 
COPD. 
(5) 
Spirometric general Classification of COPD : 
Severity Post bronchodilator 
FEV1/FCV 
FEV1% 
predicted 
 At risk  
Patients who: 
 smoke or have exposure to pollutants 
  have cough, sputum or dyspnea 
 have family history of respiratory 
disease 
>0.7 >80 
Mild COPD <0.7 >80 
Moderate COPD <0.7 50-80 
Severe COPD <0.7 30-50 
Very severs COPD <0.7 <30 
 FEV1: Forced Expiratory Volume in one second;  FVC: Forced Vital Capacity.
(4.5) 
  
The clinical severity of COPD is increasingly being recognized as being 
determined by concomitant co-morbidities apart from COPD specific features 
(i.e., hyperinflation and/or the presence of emphysema). 
(6,7)
 
Airflow obstruction has profound effects on cardiac function and gas 
exchange with systemic consequences. In addition, as COPD results from 
inflammation and/or alterations in repair mechanisms, the "spill-over" of 
inflammatory mediators into the circulation may result in important systemic 
manifestations of the disease, such as skeletal muscle wasting and cachexia.
(8)
  
Systemic inflammation may also initiate or worsen comorbid diseases, 
such as ischemic heart disease, heart failure, osteoporosis, normocytic anemia, 
lung cancer, depression, endocrinological disturbances like diabetes and 
changes in body composition. 
(8,9)
 
Involuntary weight loss as a result of an abnormal loss of  FFM which is 
a reflection of the metabolically active organs of which skeletal muscle is the 
largest, are related to typical symptoms of patients with COPD like exercise 
intolerance, muscle weakness and impaired disease-specific health status. 
Reduced body weight had an independent negative effect on muscle aerobic 
capacity in COPD patients.
 (9)
 
 Reduced capacity to perform physical exercise is a common 
manifestation in coPD, with patients presenting limitation in physical activities 
requiring normal exertion "10 and lower levels of physical activity when 
compared with healthy controls. 
(11)
   
Patients with COPD have reduced arm exercise capacity and frequently 
experienced marked dyspnea and fatigue during the performance of arm tasks 
important for daily living. 
(12)
 
Ventilatory factors underlie the limitation to arm exercise in people with 
COPD. During arm exercise, the accessory muscles of respiration are required 
for the arm task and may not be able to contribute to breathing.
 (13)
 In addition, 
since the muscles that move the arms and stabilize the trunk are attached to the 
rib cage, this increases chest wall impedance, which limits the ability to increase 
tidal volume during arm activities.
 (12,14)
 
There is a resultant shift in the respiratory load to mechanically disadvantaged 
diaphragm, which results thoraco-abdominal dyssynchrony and triggers the 
premature appearance of dyspnea and fatigue, causing reduction of upper limbs 
endurance capacity in these patients. 
(12,15) 
 
Upper limb exercises are frequently used in respiratory physiotherapy, 
with upper limb elevation and controlled inspiratory time. Dirceu Costa et al. 
have investigated the respiratory pattern of COPD patients during different 
upper limb exercises associated with respiratory exercise. They concluded that 
exercises performed with inverted respiratory time produced less thoraco-
abdominal asynchrony and can be used as important strategies during physical 
exercise programs in these patients. 
(16)
 
Still there are inconcrete evidences and lack of literatures on the influence 
of different respiratory patterns in patients with COPD. Hence, this study is 
intended to focus on the different respiratory patterns on upper limb exercise 
capacity in COPD patients. 
 
 
 
      AIMS AND OBJECTIVES OF THE STUDY 
 
 AIM :           
 1. To compare different respiratory patterns on upper limb exercise capacity 
in patients with COPD 
 OBJECTIVES : 
1. To compare the influence of different respiratory patterns on duration of 
upper limb exercise test in patients with COPD.  
2. To compare the influence of different respiratory patterns on oxygen 
saturation with upper limb exercise test in patients with COPD.  
3. To compare the influence of different respiratory patterns on rate of 
perceived exertion with upper limb exercise test in patients with COPD.  
4. To compare the influence of different respiratory patterns on heart rate 
with upper limb exercise test in patients with COPD.  
5. To compare the influence of different respiratory patterns on recovery 
period (both subjective and objective recovery) post upper limb exercise test 
in patients with COPD. 
 
 
 
 
 
 
 REVIEW OF LITERATURE 
 
1.Sundeep Salvi and Anurag Agrawal (2015) 
 stated that COPD kills more than 3 million people every year, making it the 
4th largest cause of death in the world They estimated that there are over 30 
million COPD sufferers in India. They have stated the fact that mortality 
rates due to COPD are anticipated to increase by over 160% over the next 2 
decades and half a million people die every year due to COPD in India, 
which is over 4 times the number of people who die due to COPD in USA 
and Europe. They have estimated that by the year 2030. COPD will become 
the third biggest cause of death. 
(17) 
2. Arvind Bhome (2014)  
reviewed about COPD in India with emphasis on understanding the multi-
dimensional nature of the problem and an attempt of providing insight into 
possible de-bottlenecking to reduce the pain and suffering of millions of 
COPD patients in India in future. He stated that India contributes very 
significantly to mortality from COPD 102.3/100,000 and 6,740,000 DALYs 
out of world total of 27,756,000 DALYs; thus significantly affecting Health 
related Quality of Life in the country. 
(18)
 
 3. James C Hogg and Wim Time (2013) 
 have stated that pathogenesis of COPD is based on the innate and adaptive 
inflammatory immune response to the inhalation of toxic particles and gases. 
They stated that although tobacco smoking is the primary cause of inhalation 
injury, many other environmental and occupational exposures contribute to 
the pathology of COPD. They also stated that the immune inflammatory 
changes associated with COPD are linked to a tissue-repair and remodeling 
process that increases mucus production and causes emphysematous 
destruction of the gas-exchanging surface of the lung. 
(19)
 
 4. Victor Zuniga Durado et al. (2011)  
conducted a review with an aim to discuss findings in the literature related to 
the systemic manifestations of copro emphasizing the role played by 
systemic inflammation and evaluating various therapeutic strategies. They 
stated the likely mechanisms involved in the process of local and systemic 
inflammation in this disease which include an increase in the number of 
inflammatory cells (resulting in abnormal production of inflammatory 
cytokines) and an imbalance between the formation of reactive oxygen 
species and antioxidant capacity (leading to oxidative stress). They 
concluded that both local manifestations (dyspnea and deconditioning) and 
systemic manifestation (anorexia and peripheral muscular dysfunction) leads 
to decrease exercise tolerance which in turn leads to decrease quality of life 
in COPD patients. 
(20)
  
5. Yvonne  Nussbaumer-Ochsner and Klaus F. Rabe (2011) 
 have discussed about extra-pulmonary co-morbidities which significantly 
complicates the management and influences the prognosis of patients with 
COPD. They have stated that certain co-morbidities like cardiovascular 
diseases share some risk factors with COPD, such as cigarette smoking and 
other frequently observed co-morbidities which include musculoskeletal 
wasting, metabolic syndrome, and depression cannot be easily attributed to 
smoking. They have concluded that the treatment of COPD is no longer 
focused exclusively on inhaled therapy but has taken on a multidimensional 
approach, especially because the treatment of the co- morbidities may 
positively affect the course of COPD itself. 
(21)
 
 6. Nicolas Roche et al. (2013)  
has described characteristic symptoms of COPD which includes progressive 
dyspnea, cough and sputum production as they have a considerable impact 
on patient's lives, in particular on those patients with severe COPD. They 
stated that breathlessness, which is a consequence of the characteristic lung 
hyperinflation seen in COPD, is one of the most frequently reported 
symptoms and significantly limits exercise capacity. They concluded that 
COPD symptoms in the morning are strongly associated with problems 
experienced by patients in performing simple morning activities, resulting in 
a noticeable impact on patients' quality of life. 
(22)
 
7. Toru Oga et al. (2003)  
conducted a study to analyze the relationships of exercise capacity and 
health status to mortality in patients with COPD. They enrolled l44 COPD 
patients who were available for the 5-year follow-up, 31 had died during 
course of study. Univariate Cox proportional hazards analysis revealed that 
the SGRO total score and the Breathing Problems Questionnaire were 
significantly correlated with mortality. Multivariate Cox proportional 
hazards analysis revealed that the peak oxygen uptake and the SGRQ total 
score were both predictive of mortality, independent o FEVI and age. 
Stepwise Cox proportional hazards analysis revealed that the peak oxygen 
uptake was the most significant predictor of mortality. They concluded that 
exercise capacity and health status were significantly correlated with 
mortality. 
(23) 
 8.Thomas E. Dolmage et al. (1993)  
have studied the ventilatory response to arm elevation using a customized 
arm support sling to eliminate the effect of an increase in metabolic activity 
that might be attributable to independent arm elevation and used leg exercise 
to increase metabolic activity. They found that when supported arm 
elevation (SAE) was compared with the control arm position minute 
ventilation was unchanged although the pattern of breathing (CAP), became 
more rapid and shallow. They suggested that training programs should be 
coupled with strategies that either support the arms during activity or allow 
frequent rests during which the arms are lowered. They further suggested 
that incorporating specific training and strategies for arm elevation activities 
may result in a reduction in dyspnea and an increase in the quality of life of 
patients with COPD greater than that achieved by general fitness programs 
alone. 
(24)
 
 9. Zoe J McKeough et al. (2003) 
 conducted a study to evaluate the effect of different arm positions on static 
lung volumes in COPD and healthy subjects using a plethysmography. They 
found that lung volumes were altered in COPD subjects and healthy subject 
when comparing the arm positioned above 90 degrees shoulder flexion with 
arms at or below 90 degrees of shoulder flexion. In the COPD subjects, 
breathing at higher lung volume, and having reduced capacity to have a deep 
breath when the arms were above the head, may influence the ability to 
perform everyday arm tasks that require elevation of arms above the head. 
They suggested that modification of arm tasks so that arms are only elevated 
to 90 degrees may assist in making arm work more achievable for subjects 
with COPD   
10.E.F.Porto et al. (2009)  
conducted a study of assess pulmonary hyperinflation and ventilatory 
parameters in patients with COPD after performing an exercise using the 
upper limbs and compare them in the same patients after walking on a 
treadmill using the same metabolic load, in order to evaluate the influence of 
the ventilatory pattern on the dynamics of pulmonary hyperinflation. They 
concluded that a substantial number of COPD patients, when performing 
movements with upper limbs, similar to the ones often used in daily 
activities, may hyperinflate Hyperinflation generated by an exercise using 
the upper limbs is more severe than that generated by lower limbs exercises 
when performed a the same metabolic load due to shallow breathing. 
(26)
 
11. Marcelo Colucci et al. (2010)  
conducted a study with to evaluate the development of dynamic 
hyperinflation during upper limb exercise in arm cycloergo meter with 
workloads equivalent to 50% 65%, and 80% of maxima incremental test in 
severe COPD patients. They concluded that higher workloads during a set of 
upper limb exercise in patients with severe and very severe COPD directly 
influence the reduction of the inspiratory capacity (IC), causing dynamic 
pulmonary hyperinflation. Dynamic pulmonary hyperinflation is directly 
related to a less efficient performance during the exercises and to a reduction 
in the endurance time. 
(27)
 
 12.J. Ucer C. (2004)  
has conducted study to determine the effects of 12. Cemy um work on 
breathing pattern during a well-controlled work task. They have measure the 
depth of breathing, breathing frequency and end-expiratory lung volume 
(EELV) at rest and during cycling exercise using an arm and a 
leg ergometer. They found that arm work places increased demand on 
ventilatory system including muscles of respiration that are also recruited for 
task performance. They concluded that the competition for using these 
muscles for breathing as opposed to a particular work task may result in a 
compromise in breathing capacity that ultimately may limit the ability to 
perform tasks requiring sustained heavy use of the arms. 
(28)
 
 13. Stefania Costi et al. (2009)  
have studied the effects of 15 sessions of unsupported upper extremity 
exercise training (UUEET) on functional exercise capacity, the ability to 
improve activities of daily living (ADL) and symptoms perceived during 
activities involving arms in patients with COPD. The study provided new 
and relevant data regarding benefits of UUEET on ability to perform ADL 
involving UL and fatigue related to these activities. They found that benefits 
demonstrated in exercise capacity and dyspnea during daily activities were 
still sustained after 6 months in those who received upper  extremity exercise 
training in addition to normal pulmonary rehabilitation. 
(29)
 
14. Tania Janaudis-Ferreira et al. (2011) 
 conducted study to evaluate the effect of upper extremity resistance training 
for patients with COPD on dyspnea during activity of daily living (ADL), 
arm function, arm exercise capacity, muscle strength, and health-related 
quality of life (HROL) They concluded that resistance-based arm training 
program (ATP) improved arm function, arm exercise capacity, and muscle 
strength in patients with coPD. They found out no improvements in dyspnea 
during ADL and HRQL, patients achieved a superior performance during 
tests of arm exercise capacity, without any increase in the  symptoms of 
dyspnea or arm fatigue after training, witch reflects a positive effect on the 
patients’ functional status. Their results highlighted the benefits of arm 
exercise training as part of COPD rehabilitation, as it is effective, feasible, 
and safe, and improves arm function without an increase in symptoms. 
(30)
  
15. Tetsuya Takahashi et al. (2003)  
developed a new unsupported upper limb exercise test to measure upper limb 
exercise capacity for patients with COPD They conducted study with an 
objective to examine the within patient reproducibility of unsupported upper 
limb exercise test (UULEX) and to compare the UULEX and a supported 
upper limb exercise test (SULEX) in patients with COPD. They found that 
new unsupported upper limb exercise testing is a reproducible and 
acceptable exercise test that can be used as a simple method to evaluate 
upper limb function in COPD patients.
(31)
  
16. Dirceu Costa et al. (2011)  
have conducted a study to investigate the respiratory pattern of COPD 
patients during different upper limb exercises associated with respiratory 
exercises. Respiratory pattern was analyzed using inductance 
plethysmography during four types of upper limb exercise, two shoulder 
flexion-extention (one associated with inspiratory time during concentric 
phase and other associated with expiratory time) and two shoulder abduction 
and adduction(same timing as above). They found that exercises performed 
with inverted respiratory time produced less thoraco-abdominal asynchrony. 
They suggested that inverted respiratory patterns can be used as important 
strategies during physical exercise program in COPD patients. 
(16) 
 
 
 
 
 
 
 
 
 METHODOLOGY 
 
 
STUDY DESIGN  
 Cross sectional study.  
 
INCLUSION CRITERIA: 
 Stable diagnosed cases of COPD patients  
 Receiving pulmonary drugs  
 Smokers or former smokers  
 
 
EXCLUSION CRITERIA  
 Age above 80 years  
 Any musculoskeletal disorder that interferes performance  
 Uncontrolled arterial hypertension  
 Significant cardiovascular disorder 
 History of cerebrovascular accident 
 Clinically unstable condition  
 
 
TOOLS USED FOR THE STUDY  
 Pulse oximeter  
 Metronome  
 Stop watch 
 Borg’s scale (6-20)          
  
POPULATION AND SAMPLE  
The study was carried out in various hospital and old age homes in 
coimbatore. Twenty two patients suffering from COPD were recruited. The 
patients were screened for inclusion and exclusion criteria and those who fulfill 
the criteria were included for the study.  
This study was approved by the institute ethical committee of PPG 
college of physiotherapy. 
 
SAMPLING: Convenient Sampling  
 
DATA COLLECTION  
Voluntary participation for the study was considered. An informed 
consent was obtained from each participant. Consent from hospital and old age 
homes authorities was obtained after explaining the objectives as well as 
method of the study.  
Data were collected from the month of August 2013 January 2014.  
The demographic data were obtained initially and it includes variables 
like name, age, sex, height, weight. BMI, smoking status, stage of COPD. 
oxygen saturation and phone numbers were noted. 
 The subjects were taught any one of the exercise (randomly selected one 
out of 4 exercises) (learning phase). After 10 minutes of rest period, upper limb 
exercise testing was performed by using randomly selected one out of 4 
exercises mentioned in the task (exercise test phase).  
Rate of perceived exertion using Borg's scale (6-20) and oxygen 
saturation using pulse oximetry were measured, before and after the exercise 
test phase.    
 
  
 
Metronome was used to maintain the pace of exercise test. The pace was 
set at 20 beats per min and on each beat patient completed one full cycle of 
respiration along with the upper limb task.  
The duration for which the exercise tests were performed was recorded 
using a stopwatch.  
Exercise testing was terminated when  
i. Patient was unable to maintain pace with metronome  
ii. Had a sense of fatigue or discomfort  
iii. Oxygen saturation falls below 88%.
(32)
  
A washout period of 48 hours was given between each exercise test.  
TASK  
1
st
 Exercise: subjects were asked to perform shoulder flexion from 180° to 0° 
(upper limbs elevation) with inspiration, and return to the initial position with 
expiration (shoulder extension: 180° to 0°).  
2
nd
 Exercise: subjects were asked to perform shoulder flexion from 0
o
 to 180
o
 
(upper limbs elevation) with expiration, and return to the initial position with 
inspiration (shoulder extension: 180° to 0°).  
3rd Exercise: subjects were asked to perform shoulder horizontal abduction 
(initial position: shoulder flexion at 90) with inspiration, and return to the initial 
position with expiration (shoulder horizontal adduction)  
4
th
 Exercise: subjects were asked to perform shoulder horizontal abduction 
(initial position: shoulder flexion at 90
o
 with expiration, and return to the initial 
position with inspiration (shoulder horizontal adduction) 
 
DATA PROCESSING AND STATISTICAL ANALYSIS  
Data were coded according to coding scheme and a master chart was 
prepared for further statistical analysis. Data were analyzed using IBM SPSS 
20.0.  
Descriptive statistics, Independent t-test. Wilcoxon signed ranked t test 
and Friedman test were used for analysis of data.  
1. ARITHMETIC MEAN  
2. STANDARD DEVIATION (S D)  
 
 
 
 
 
 
 
 
 
 
 
 
 RESULTS 
 
 Normality of collected data was established by Shapiro-Wilk test as 
sample size was less than 50. Here the outcome data did not followed the 
normal distribution therefore non parametric test of significance was used. 
While the demographic data followed normal distribution therefore expressed in 
mean and standard deviation (SD). Wilcoxon signed ranked t-test was used to 
analyze significant difference within pre and post exercise testing for SpO2. 
Borg's score, heart rate and also for difference within recovery 1 (subjective) 
and recovery 2 (objective). Friedman test was used to analyze significant 
difference between all four UL exercise tests. 
 
TABLE : 5.1:  Demographic characteristics of the patients 
CHARACTERISTIC N = 22 
Age, mean (SD), Years 67.5(5.6) 
Height, mean (SD), cm 162.3(6.9) 
Weight, mean (SD), kg 62.4(7.7) 
BMI, mean (SD),kg/ms 23.9(2.9) 
Moderate COPD (n) 12 
Severe COPD (n) 10 
 
 
 
 
TABLE : 5.2:  Gender distribution of the subjects 
PARAMETER MALE FEMALE p-value 
N 9 13  
Age, mean (SD), year 68.7 (3.7) 6.7 (6.6) 0.40 
Height, mean (SD), cm 163.8 (7.2) 161.3 (6.7) 0.42 
Weight, mean (SD), kg 64.4 (8.5) 61 (7.03) 0.31 
BMI, mean (SD),kg/m
2
 24.5 (2.9) 23.4 (3.4) 0.40 
 
The table 5.2 shows that there was no significant difference between male and 
female population in the steady with respect to baseline characteristics. 
TABLE : 5.3:  Duration for which each exercise was performed. 
EXERCISE DURATION 
 
(in seconds) 
p-value p-value 
1 75 (52, 84)  
0.002 
 
=0.07 2 94 (56, 120) 
3 66 (51.3, 105.8)  
<0.001 4 98 (63.8, 148.5) 
 
The table 5.3  suggests that exercise 4 was performed for longer duration of 
time followed by exercise 2, exercise 3 and exercise 1 respectively. The p-value 
of 0.007 was established between all four exercise tests suggesting of weak 
significant difference between each. There was significant difference between 
exercise 1 and exercise 2 with p-value of 0.002; and between exercise 3 and 
exercise 4 with p-value of <0.001. 
TABLE : 5.4:  Difference in oxygen saturation within each exercise. 
EXERCISE SpO2 (PRE) % SpO2 (POST) % p-value 
1 96(95.8, 97) 96 (93.5, 97) =0.01* 
2 97 (96,97) 96.5 (95.7, 98) 0.34 
3 96 (95,97) 95 (92.8, 97) <0.046* 
4 96(95.8,97) 98.5 (96.8, 99) 0.001** 
 
The Table 5.4 shows that, there was significant change in oxygen saturation pre 
and post exercise capacity test within exercise 1, exercise 3 and exercise 4. 
 
TABLE : 5.5:  Difference in heart rate (HR) within each exercise. 
EXERCISE HR (PRE) (bpm) HR (POST) (bpm) p-value 
1 79.5 (73,97) 95.5 (86.5, 100.5) 0.004** 
2 79.5 (77, 86.8) 92 (82,102.5) 0.003** 
3 83 (72,89) 99 (92, 106.5) <0.001** 
4 83 (75.8, 87.3) 99.5 (84.3, 110.5) <0.001** 
 
The table 5.5 shows that, there was significant rise in heart rate in all four 
exercises post exercise capacity testing. 
 
 
 
TABLE : 5.6:  Difference in Borg’s score within  each exercise. 
EXERCISE BORG’S (PRE) BORG’S (POST) p-value 
1 10 (9,11) 13 (12.8,14) <0.001** 
2 9.5 (8.7,12) 13 (12.7, 14) <0.001** 
3 10 (9,12) 14 (12.8, 14.3) <0.001** 
4 10 (9,12) 14 (12,15) =0.001** 
 
The table 5.6 shows that, there was significant rise in the Borg’s score within all 
four exercise post exercise testing. 
 
TABLE : 5.7:  Difference in Recovery (1=subjective; 2=objective) witnin group 
EXERCISE RECOVERY 1 
(second) 
RECOVERY 2 
(second) 
p-value 
1 50.5 (36.8, 59.3) 71 (59,123.5) <0.001** 
2 30 (20,56) 66.5 (42.7, 102.25) <0.001** 
3 36 (30.8, 55) 78.5 (49.8, 150.3) <0.001** 
4 37 (24.5, 59.3) 86 (54.5, 120) =0.001** 
 
The table 5.7 conclude that, there was significant difference between recovery 1 
(subjective) and recovery 2 (objective) within all 4 exercise post exercise 
capacity testing. 
 
 
TABLE : 5.8:  Data for outcome measures for all four exercise at baseline. 
EXERCISE 
 
OUTCOME 
MEASURES 
1 2 3 4 p-value 
SpO2 (median) % 
IQR 
96 
(95.8, 97) 
97 
(96,97) 
96 
(95,97) 
96 
(95.8,97) 
0.53 
Borg’s Score (median)  
IQR 
10 
(9, 11) 
9.5 
(8.7, 12) 
10 
(9, 12) 
9.5 
(9, 12) 
0.54 
Heart rate (median)  
bpm 
IQR 
79.5 
(73,97) 
79.5 
(77,86.8) 
83 
(77,89) 
83 
(75.8, 
87.3) 
0.95 
 
The table 5.8 shows that, there was no significant difference between each 
exercise at baseline with respect to Spo2, Borg’s score and Heart rate. 
 
 
 
 
 
 
 
 
 
TABLE : 5.9:  Data for outcome measures for all four exercise post exercise testing. 
EXERCISE 
 
OUTCOME 
MEASURES 
1 2 3 4 p-value 
SpO2 (median) % 
IQR 
96 
(93.5, 97) 
96.5 
(95.7, 98) 
95 
(92.8,97) 
98.5 
(96.8, 99) 
<0.001** 
Borg’s Score (median)  
IQR 
13 
(12.8, 14) 
13 
(12.75, 14) 
14 
(92.109.5) 
14 
(12,15) 
0.70 
Heart rate (median)bpm 
IQR 
95.5 
(86.5, 100.5) 
92 
(82, 102.5) 
99 
(92.109.5) 
99.5 
(84.3, 110.5) 
0.31 
Recovery 1 (median) 
IQR 
50.5 
(36.8, 59.3) 
30 
(20,56) 
36 
(30.8, 55) 
37 
(24.5, 59.3) 
0.19 
Recovery 2 (median) 
IQR 
71 
(59, 123.5) 
66.5 
(42.7,102.3) 
78.5 
(49.8,150.3) 
86 
(54.5, 120) 
0.51 
 
The table 5.9 states that, there was significant difference between all four 
exercises in SpO2 post exercise testing. 
 
 
 
 
 
 
DISCUSSION 
The main finding of this study is that the patient with COPD are better 
able to perform for longer duration with inverted breathing pattern (expiration 
during concentric phase of UL movement) when compared with the results of 
frequently applied in exercise clinical practice (inspiration during concentric 
phase of UL movement). In addition, among the studied exercises, exercise 4 
(task 4) shows significant increase in SpO2 post exercise with prolonged 
recovery 2 (objective) period for the same exercise suggesting that the gain in 
SpO2 was maintained for longer time as compare to other exercise. 
 In 2007, Rabe et al observed that COPD could be the third most common 
cause of death worldwide by 2020.
(33)
In 2000, Donner and Bjermer observed 
that ''although COPD is a major disease worldwide there is a perplexing current 
uncertainty about the nature of this disease" and that "COPD begins as a local 
inflammation in the lungs, and through differentiated pathways still to be 
clarified, this leads to systemic consequences”. (34) 
 In this direction, some studies have also related that although COPD is a 
respiratory disease affecting the lungs, it is known that its effects are not 
exclusively limited to the respiratory system, Consequently, there are non 
respiratory manifestations including skeletal muscle dysfunction with atrophy 
and weakness, systemic inflammation, nutritional depletion and malnutrition, 
which can contribute to exercise imitation and affect patients’ function and 
mobility.
(20,35-38)
In their study, Papaioannou et al. observed that higher systemic 
levels of oxidative stress in COPD patients may contribute to a reduction in the 
body mass and fat-free mass indexes, thereby contributing to impaired exercise 
capacity.
(39)
  
From this aspect, studies have shown that in COPD patients, the 
peripheral muscles are frequently affected, involving respiratory as well as 
upper and lower limbs muscles. According to Levine et al.
 (40)
and Gosker et 
al.
(41)
 patients with COPD a higher present ratio of type I fibers in the 
diaphragm muscle and this process can contribute to the reduction in force 
generation. In contrast, peripheral muscles dysfunction is characterized by a 
reduction in the percentage of oxidative fibers (type in relation to glycolytic 
fibers, thus contributing to reduction in the oxidative capacity of these   
muscles.
(42,43)
 Due to dysfunction and atrophy in the striated skeletal muscles, 
COPD patients may show reduced exercise capacity in addition to impaired 
quality of life and an increased mortality rate.
(44,45)
 
Tasks involving upper limbs vary considerably. They commonly involve 
lifting the upper limbs forward a movement that is both unsupported and 
dynamic. As a corollary, activities such as combing hair, brushing teeth or 
shaving involve UL movements and shoulder muscles without support i', in 
which the accessory muscles of inspiration assist the positioning of the trunk 
and upper limbs. This activities contributes to increased demand on these 
muscles and diaphragm overload, resulting in inspiratory movements with 
thoraco abdominal asynchrony and the premature appearance of dyspnea and 
leg fatigue, limiting the endurance of the upper limbs ''According to Casaburi 
and Petty, the low tolerance of COPD patients during UL exercises is due to the 
fact that the shoulder and thorax muscles participate in the respiratory processes 
and shoulder movements.
 (46)
   
In clinical practice, UL exercises can be performed with and without 
support. Among those without support are the exercises used in this study, 
specifically shoulder flexion and horizontal abduction-adduction, which can be 
associated with the respiratory pattern, considering expiration during concentric 
phase of the movements.  
Very few studies related to different respiratory pattern has been 
conducted. In 2011, Dirceu C et al. studied respiratory pattern of COPD patients 
during different UL exercises associated with respiratory exercises, and showed 
that in exercises performed with inverted respiratory time there was no increase 
in thoraco-abdominal asynchrony when compared with the rest condition and 
other exercise.
 (16)
 However, there are no studies relating respiratory pattern and 
upper limb exercise capacity during the different respiratory patterns associated 
with these exercises performed with inverted movements by patients with 
COPD  
Hussain et al. reported that the ribcage muscles are recruited for multiple 
activities, such as breathing, postural support, and stabilization during the tasks 
performed with UL and their positioning.
 (47)
 When there is an increase in 
ventilatory necessity, such as in physical exercise, the accessory and expiratory 
muscles are recruited. When the coordination of these muscles with the primary 
motor muscles of inspiration is altered, it can cause airway obstruction, thoracic 
wall distortion and inefficient muscle actions, and all these alterations cause 
disadvantage in respiratory work.
 (15)
    
Celli et al. also studied the ventilatory and metabolic responses during UL 
exercises without support in COPD patients and showed that this exercise 
promoted thoraco-abdominal asynchrony, followed by dyspnea.
(15)
 In 
1992,Couser et al. observed that arm elevation in normal subjects promoted an 
increase in ventilatory and metabolic demands similar to mild exercise with 
changes in ribcage and or abdominal mechanics.
 (48)
   This can help to explain 
the limitation in exercise tolerance observed in unsupported UL activities in 
these subjects and this could be more relevant in COPD patients whose 
diaphragm muscles are less effective.  
In our study, exercise 2 and exercise 4, in which the respiratory 
movement was inverted, were able to perform for longer duration of time when 
compared to exercise 1 and exercise 3 with p value of 0.002 and p value 40.001 
respectively. A possible explanation for this is that during inspiration, when the 
UL are turned down (as in exercise 2), it decreases the double action of 
accessory muscles: differently from exercise and exercise 3. in which the 
accessory muscles assist the UL during the rising movement. This decreases 
work load on accessory muscles thereby delaying fatigue to set in. 
Significant rise in SpO2 during exercise 4 could be the result of 
intensification of breathing that was being achieved only by the muscles 
responsible for the action, w interference by the accessory muscles in the 
movement, probably without overloading th diaphragm. Although the exercise 4 
has shown rise in SpO2 excrcise 2 showed slight fall in SpO2 which was not 
significant when compared to exercise 1 and exercise 3 where the fall in spos 
was significant. In exercise 1 and exercise 3. the decrease in SpO2 can be 
explained by the combined movement of shoulder flexion, shoulder abduction 
and assistance with breathing, while in exercise 2 and exercise 4. the inversion 
of breathing helped to inhibit the accessory muscles of respiration, restricting 
them to only their main action during the shoulder exercise.  
During exercises 3 and 4. it is important to emphasize the inversion of  
respiratory movements associated with the intense use of accessory muscles of 
respiration related to the ribcage expansion movement. In the horizontal 
abduction movement with inspiration, the muscles assist in inspiration and also 
in ribcage expansion, in this context, operating in the two functions, while 
during the horizontal adduction with inspiration, the ribcage expansion is more 
restricted, which could minimize action of the accessory muscles as well as 
hyperinflation associated with upper limb exercise in these patients. This could 
explain why there was improvement in upper limb exercise capacity in this type 
of exercise, with the reduced function of the accessory muscles of respiration.
 Some muscles of the superior part of the thorax and scapular girdle, 
which serve for respiratory and postural functions, have thoracic and extra 
thoracic attachment points, such as the inferior/superior trapezius latissimus 
dorsi, serratus anterior, subclavius and pectoralis major and minor. In COPD 
patients with pulmonary hyperinflation, which frequently occurs, the diaphragm 
lowers and loses its capacity to generate force, so that the ribcage muscles 
become more important to generate the inspiratory pressures. in this sense, and 
based on the results of the present study, it is suggested that exercises that 
minimize the action of accessory muscles of inspiration are more appropriate for 
COPD patients, because they direct the inspiratory movement to the muscles 
suitable for the movement, especially the diaphragm muscle. 
Limitations of the study: 
 Small sample size  
 Lack of sophisticated assessment tools for assessing exercise 
capacity of upper limb.  
 scarcity of studies about the issue and methodology used.  
Future recommendations:  
 Longitudinal studies should be done to find the prolonged effects 
of inverted respiratory patterns in COPD as well as in healthy 
population. 
 Future studies could relate this strategy to the breathing retraining  
during upper limb 
 
 
CONCLUSION 
The exercises performed with inverted respiratory time (exercise 2 and 
exercise 4) were able to perform better than other exercise (exercise l and 
exercise 3).  
In addition, among the studied exercises, exercise 4 (task 4) shows significant 
increase in SpO2 post exercise with prolonged recovery 2 (objective) period for 
the same exercise suggesting that the gain in SpO2 was maintained for longer 
time as compare to other exercise. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                          SUMMARY 
Globally, COPD has emerged as the major cause of morbidity and 
mortality expected to become the 3
rd
 most leading cause of death and 5
th
  
leading cause of loss of ‘Disability Adjusted Life Years’ as per projection of the 
global burden of disease study.  
Patients with COPD have reduced arm exercise capacity and frequently 
experienced marked dyspnea and fatigue during the performance of arm tasks 
important for daily living.  
The present study aimed to compare different respiratory patterns on 
upper limb exercise capacity in patients with COPD  
Twenty two COPD patients were recruited in the study from various 
hospital and old age homes across Mangalore. Upper limb exercise capacity was 
measured in all four types of exercises two shoulder flexion-extension (one 
associated with inspiratory time during the concentric phase and the other 
associated with expiratory time) and two shoulder abduction-adduction (same 
timing as above). SpO2, Borg’s score and heart rate was noted pre and post UL 
exercise testing. Recovery both subjective and objective was noted post exercise 
testing.  
The study concluded that the exercises performed with inverted were able 
to perform better than other exercise and can be used as important strategies 
during physical exercise programs in these patients.  
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ANNEXURE 
ANNEXURE-I 
INFORMED CONSENT FORM 
TITLE:  
 
 
INVESTIGATOR: _ _ _ _ _ _ _ _ _ _ _  
PURPOSE OF THE STUDY:  
I_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  ,have been informed that this study will work towards  
improving  Pulmonary function in male sedentary workers. 
PROCEDURE:  
Each term of the study protocol has been explained to me in detail. I understand that during 
the procedure, I will be receiving the treatment for one time a day. I understand that I will 
have to take this treatment for four weeks.  
I understand that this will be done under investigator, _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
supervision. I am aware also that I have to follow therapists instructions as has been told to 
me.  
CONFIDENTIALITY:  
I understand that medical information provided by this study will be confidential. If the data 
are used for publication in the medical literature or for teaching purposes, no names will be 
used and other literature such as audio or video tapes will be used only with permission.  
RISK AND DISCOMFORT: I understand that there are no potential risks associated with 
this procedure, and understand that investigator will accompany me during this procedure. 
There are no known hazards associated with this procedure  
. REFUSAL OR WITHDRAWL OF PARICIPATION:  
I understand that the decision my participation is wholly voluntary and I may refuse 
participate, may withdraw consent at any time during the study.  
I also understand that the investigator may terminate my participation in the study at anytime 
after researcher has explained me the reasons to do so.  
I _ _ _ _ _ _ _ _ _ _ _ _ _ _ have explained to …………………………………. the purpose 
of the research, the procedures required and the possible risks and benefits, to the best 
of my ability.  
…………………………………… ……………………………  
Investigator Date  
I ………………………………. Confirm that researcher has explained me the purpose of 
the research, the study procedure and the possible risks and benefits that I may 
experience. I have read and I have understood this consent to participate as a subject in 
this research project.  
…………………….. …………………………  
Subject Date  
……………………….. ………………………….  
 
 
 
 
Signature of the Witness  
Date 
 
 ANNEXURE-1 
ANNEXURE-2 
ASSESSMENT FORM         
Date:    
Name:  
Age:      Gender:  
Height (cm) :   Weight (kgs):  
BMI:  
Smoking status:  
Stage of COPD:  
Oxygen saturation at the time of assessment: 
 Associated chronic conditions HTN       (controlled uncontrolled)  
      DM   (controlled uncontrolled)  
Cardiovascular disorder  
History of previous episode of exacerbation:  
 
History of medications taken:  
 
Any Musculoskeletal disorder:  
History of Cerebrovascular disease: 
